2021
DOI: 10.1039/d0tb02529a
|View full text |Cite
|
Sign up to set email alerts
|

Ubiquinone-BODIPY nanoparticles for tumor redox-responsive fluorescence imaging and photodynamic activity

Abstract: A ubiquinone-BODIPY photosensitizer self-assembles into nanoparticles (PS-Q-NPs) and undergoes selective activation within the highly reductive intracellular environment of tumors, resulting in “turn-on” fluorescence and photosensitizing activities.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 79 publications
0
6
0
Order By: Relevance
“…To this end, Kim et al reported a GSH-activatable PDT agent (86), where a GSHsensitive moiety (a ubiquinone analogue) was covalently linked to a near-infrared PS (a meso-ester-2,6-iodinated-BODIPY) via an ester linkage (Figure 37). 325 Compound 86 is strongly hydrophobic and easily aggregates to form nanoparticles in aqueous solutions. Not only does this result in quenched photosensitivity and minimal systemic toxicity, but this also favors tumor enrichment through the EPR effect.…”
Section: Gsh Mediated Reductionmentioning
confidence: 99%
See 1 more Smart Citation
“…To this end, Kim et al reported a GSH-activatable PDT agent (86), where a GSHsensitive moiety (a ubiquinone analogue) was covalently linked to a near-infrared PS (a meso-ester-2,6-iodinated-BODIPY) via an ester linkage (Figure 37). 325 Compound 86 is strongly hydrophobic and easily aggregates to form nanoparticles in aqueous solutions. Not only does this result in quenched photosensitivity and minimal systemic toxicity, but this also favors tumor enrichment through the EPR effect.…”
Section: Gsh Mediated Reductionmentioning
confidence: 99%
“… Chemical structure of 86 conjugate and conversion to 87 under reductive conditions. Reproduced with permission from ref ( 325 ). Copyright 2019 The Royal Society of Chemistry.…”
Section: Theranostic Fluorescence Probes In Cancer Therapymentioning
confidence: 99%
“…The reduction of ubiquinone to the hydrophilic carboxylate resulted in increased fluorescence and the generation of therapeutic singlet oxygen ( 1 O 2 ) (Table 2). 159 Recently, Chakravarty and co-workers reported the iron( iii ) catecholate of BODIPY 164 containing the dipicolylamine ligand, which shows a ligand-to-metal charge transfer (L→M CT) band at ∼800 nm (Fig. 19).…”
Section: Applications Of Bodipy Chromophoresmentioning
confidence: 99%
“…It is well-known that detection methods are expanding rapidly worldwide, but the use of fluorescent techniques for the detection of analytes is always ahead of other techniques and has become a hot subject in chemical research due to its high sensitivity, selectivity, affordability, and ease of use. Schiff-base ligands with potential fluorophores and extended conjugation are mainly used to detect Ga 3+ because of their far absorption and emission properties and the formation of the geometric cavity for chelation. One more important factor is the selectivity, which is lacking in many chemosensors due to their multiple detection ability for many group 13 metal ions. In group 13, the size of the Al is more than Ga due to the well-known d-contraction in Ga (poor shielding effect of the 3d-electrons). Therefore, having hard donor sites with comparatively smaller cavity sizes prefers Ga 3+ more prominently over Al 3+ .…”
Section: Introductionmentioning
confidence: 99%